03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Epirubicine Mylan 50mg : | |
Type | Medicine Authorised |
Originator | Farmorubicin 50mg* |
Agent | Benta Trading Co |
Distributor | Benta Trading Co |
Laboratory | Mylan |
Manufacturer | Benta SAL |
Manufacturing Type | Benta SAL under license from Mylan S.A.S. France |
Origin | Lebanon |
ATC | L01DB03 |
Epirubicine Mylan 50mg :
Epirubicine Mylan 50mg :
Epirubicine Mylan 50mg :
Epirubicine Mylan 50mg :
Epirubicine Mylan 50mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Epirubicine Mylan 50mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute lymphocytic leukaemia (Acute lymphoblastic leukemia) | Rare |
Acute myeloid leukaemia | Rare |
Alopecia | Very Common |
Amenorrhoea (amenorrhea) | Rare |
Anaemia | Very Common |
Anaphylaxis | Rare |
Anorexia | Common |
Arrhythmia | Rare |
Ascites | Rare |
Asthenia | Rare |
Atrioventricular block (AVB) | Rare |
Azoospermia | Rare |
Bradycardia | Rare |
Bundle branch block | Rare |
Cardiomyopathy | Rare |
Cardiotoxicity | Rare |
Chemical cystitis | Common |
Chills | Rare |
Congestive heart failure | Rare |
Conjunctivitis | Not known |
Cystitis haemorrhagic | Common |
Dehydration | Common |
Diarrhoea (Diarrhea) | Common |
Dyspnoea (dyspnea) | Rare |
Erythema | Not known |
Febrile neutropenia (Neutropenic fever) | Very Common |
Fever | Rare |
Gallop rhythm | Rare |
Granulocytopenia | Very Common |
Haemorrhage | Not known |
Hepatomegaly | Rare |
Hot flush | Common |
Hyperuricaemia | Rare |
Infection | Common |
Infusion site erythema | Common |
Itching | Not known |
Keratitis | Not known |
Left ventricular ejection fraction decreased | Not known |
Leucopenia (Leukopenia) | Very Common |
Malaise | Rare |
Nail pigmentation | Not known |
Nausea | Common |
Neutropenia | Very Common |
Oedema | Rare |
Oesophagitis | Common |
Oral discharge | Common |
Phlebitis | Uncommon |
Photosensitivity | Not known |
Pleural effusion | Rare |
Pneumonia | Not known |
Pulmonary embolism | Not known |
Pulmonary oedema | Rare |
Radiation recall reaction (dermatologic) | Not known |
Redness | Not known |
Sepsis (Systemic infection) (Sepsis state) | Not known |
Septic shock | Not known |
Shock | Not known |
Skin changes | Not known |
Skin hyperpigmentation | Not known |
Skin rash | Not known |
Stomatitis | Common |
Thrombocytopenia (Thrombopenia) | Uncommon |
Thromboembolism | Not known |
Thrombophlebitis | Uncommon |
Transaminases abnormal | Rare |
Urine coloring red | Very Common |
Urticaria | Rare |
Ventricular tachycardia | Rare |
Vertigo | Rare |
Vomiting | Common |
Epirubicine Mylan 50mg :
NB : Products With Same Indication |
Different Units By MoH Code
Epirubicine Mylan 50mg MoH 6654 :
Form | Solution for injection |
Packaging | Bottle |
Package Size | 1x25ml |
Strength | 50mg |
Public Price | 3654772.72 L.L. |
Stratum | B |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 218858/09 |
Submission date | 01/01/2009 |
Registration Year | 2012 |
Price Comparison
● Country: | Tunisia | |
● Package Size: | 1x25ml | |
● Public Price: | 216 TND | ( 6,234,840.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 216 TND | ( 6,234,840.00 LBP ) |
● Pricing Date: | 04/02/2019 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Solution for injection | |
● Package Size: | 1x25ml | |
● Public Price: | 3654772.72 LBP | ( 3,654,772.72 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3654772,72 LBP | ( 3,654,772.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | France |
● Package Size: | 1 |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
● Country: | The Netherlands |
● Package Size: | 1 |
● Reference: | Zorginstituut Nederland |
● Pricing Date: | 15/06/2019 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File